University of Tasmania
Browse

File(s) under permanent embargo

Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge

journal contribution
posted on 2023-05-20, 17:03 authored by Lei SiLei Si, Willis, MS, Asseburg, C, Nilsson, A, Tew, M, Clarke, PM, Lamotte, M, Ramos, M, Shao, H, Shi, L, Zhang, P, McEwan, P, Ye, W, Herman, WH, Kuo, S, Isaman, DJ, Schramm, W, Sailer, F, Brennan, A, Pollard, D, Smolen, HJ, Leal, J, Gray, A, Patel, R, Feenstra, T, Andrew PalmerAndrew Palmer
Objectives: The cardiovascular outcomes challenge examined the predictive accuracy of 10 diabetes models in estimating hard outcomes in 2 recent cardiovascular outcomes trials (CVOTs) and whether recalibration can be used to improve replication.

Methods: Participating groups were asked to reproduce the results of the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) and the Canagliflozin Cardiovascular Assessment Study (CANVAS) Program. Calibration was performed and additional analyses assessed model ability to replicate absolute event rates, hazard ratios (HRs), and the generalizability of calibration across CVOTs within a drug class.

Results: Ten groups submitted results. Models underestimated treatment effects (ie, HRs) using uncalibrated models for both trials. Calibration to the placebo arm of EMPA-REG OUTCOME greatly improved the prediction of event rates in the placebo, but less so in the active comparator arm. Calibrating to both arms of EMPA-REG OUTCOME individually enabled replication of the observed outcomes. Using EMPA-REG OUTCOME–calibrated models to predict CANVAS Program outcomes was an improvement over uncalibrated models but failed to capture treatment effects adequately. Applying canagliflozin HRs directly provided the best fit.

Conclusions: The Ninth Mount Hood Diabetes Challenge demonstrated that commonly used risk equations were generally unable to capture recent CVOT treatment effects but that calibration of the risk equations can improve predictive accuracy. Although calibration serves as a practical approach to improve predictive accuracy for CVOT outcomes, it does not extrapolate generally to other settings, time horizons, and comparators. New methods and/or new risk equations for capturing these CV benefits are needed.

History

Publication title

Value in Health

Volume

23

Issue

9

Pagination

1163-1170

ISSN

1098-3015

Department/School

Menzies Institute for Medical Research

Publisher

Blackwell Publishing Inc

Place of publication

350 Main St, Malden, USA, Ma, 02148

Rights statement

Copyright 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC